The drugmaker said UBT251 achieved mean body weight reduction of up to 9.8% after a 24-week trial.
Discover more from InfoVera USA
Subscribe to get the latest posts sent to your email.
US News, Trends & Trusted Information
The drugmaker said UBT251 achieved mean body weight reduction of up to 9.8% after a 24-week trial.
Subscribe to get the latest posts sent to your email.
Subscribe now to keep reading and get access to the full archive.